Impact of atrial fibrillation on outcome in thrombolyzed patients with stroke: Evidence from the virtual international stroke trials archive (VISTA)

Stroke

Volumn 43, Issue 7, 2012, Pages 1872-1877

  Frank, Benedikt ^a,b   Fulton, Rachael ^a   Weimar, Christian ^b   Shuaib, Ashfaq ^c   Lees, Kennedy R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

age; atrial fibrillation; outcomes; stroke management; thrombolysis

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL (TOPIC); COCHRAN MANTEL HAENSZEL TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; STATISTICAL ANALYSIS; STROKE; STROKE PATIENT;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DATABASES, FACTUAL; FEMALE; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; SICKNESS IMPACT PROFILE; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84863302156     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.650838     Document Type: Article

References (27)

1. Saver JL, Gornbein J, Grotta J, Liebeskind D, Lutsep H, Schwamm L, et al. Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3-to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial. Stroke. 2009;40:2433-2437.
2. Mishra NK, Ahmed N, Davalos A, Iversen HK, Melo T, Soinne L, et al. Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology. 2011;77:1866-1872.
3. Mishra NK, Ahmed N, Andersen G, Egido JA, Lindsberg PJ, Ringleb PA, et al. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ. 2010;341:c6046.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
5. Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T. Atrial fibrillation as an independent predictor for no early recanalization after IV-tPA in acute ischemic stroke. J Neurol Sci. 2008;267:57-61. (Pubitemid 351248907)
6. Kimura K, Iguchi Y, Shibazaki K, Iwanaga T, Yamashita S, Aoki J. IV tPA therapy in acute stroke patients with atrial fibrillation. J Neurol Sci. 2009;276:6-8.
7. Sanak D, Herzig R, Kral M, Bartkova A, Zapletalova J, Hutyra M, et al. Is atrial fibrillation associated with poor outcome after thrombolysis? J Neurol. 2010;257:999-1003.
8. Seet RC, Zhang Y, Wijdicks EF, Rabinstein AA. Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis. Arch Neurol. 2011;68:1454-1458.
9. Generalized efficacy of tPA for acute stroke. Subgroup analysis of the NINDS tPA Stroke Trial. Stroke. 1997;28:2119-2125.
10. Bluhmki E, Chamorro A, Davalos A, Machnig T, Sauce C, Wahlgren N, et al. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009;8:1095-1102.
11. Zhang JB, Ding ZY, Yang Y, Sun W, Hai F, Sui XN, et al. Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation. Neurol Res. 2010;32:353-358.
12. Ali M, Bath PMW, Curram J, Davis SM, Diener HC, Donnan GA, et al. The Virtual International Stroke Trials Archive. Stroke. 2007;38: 1905-1910. (Pubitemid 46847267)
13. Mishra NK, Lyden P, Grotta JC, Lees KR. Thrombolysis is associated with consistent functional improvement across baseline stroke severity: a comparison of outcomes in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke. 2010;41:2612-2617.
14. Konig IR, Ziegler A, Bluhmki E, Hacke W, Bath PM, Sacco RL, et al. Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke. 2008;39: 1821-1826.
15. Kimura K, Sakamoto Y, Aoki J, Iguchi Y, Shibazaki K, Inoue T. Clinical and MRI predictors of no early recanalization within 1 hour after tissue-type plasminogen activator administration. Stroke. 2011;42: 3150-3155.
16. Baizabal-Carvallo JF, Rosso C, Alonso-Juarez M, Pires C, Samson Y. The hemodynamic status within 24 h after intravenous thrombolysis predicts infarct growth in acute ischemic stroke. J Neurol. 2011;5:5.
17. Tsivgoulis G, Saqqur M, Sharma VK, Lao AY, Hoover SL, Alexandrov AV. Association of pretreatment ASPECTS scores with tPA-induced arterial recanalization in acute middle cerebral artery occlusion. J Neuroimaging. 2008;18:56-61.
18. Liebeskind DS, Sanossian N, Yong WH, Starkman S, Tsang MP, Moya AL, et al. CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke. 2011;42:1237-1243.
19. Marder VJ, Chute DJ, Starkman S, Abolian AM, Kidwell C, Liebeskind D, et al. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke. 2006;37:2086-2093. (Pubitemid 44309909)
20. Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, et al. Cardioembolic vs noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis. 2000;10:39-43. (Pubitemid 30034856)
21. Miller VT, Pearce LA, Feinberg WM, Rothrock JF, Anderson DC, Hart RG. Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Neurology. 1996;46:238-240. (Pubitemid 26156137)
22. Adams HP, Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41. (Pubitemid 23014379)
23. Awadh M, MacDougall N, Santosh C, Teasdale E, Baird T, Muir KW. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation. Stroke. 2010; 41:1990-1995.
24. Tu HT, Campbell BC, Christensen S, Collins M, De Silva DA, Butcher KS, et al. Pathophysiological determinants of worse stroke outcome in atrial fibrillation. Cerebrovasc Dis. 2010;30:389-395.
25. Conway DS, Heeringa J, Van Der Kuip DA, Chin BS, Hofman A, Witteman JC, et al. Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study. Stroke. 2003;34:413-417. (Pubitemid 36206340)
26. Roldan V, Marin F, Garcia A, Tello-Montoliu A, Lip GY. Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation? Int J Cardiol. 2006;110:265-266. (Pubitemid 43767105)
27. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703.